{"altmetric_id":1420258,"counts":{"readers":{"mendeley":9,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["IHC_Ophth"],"posts_count":1}},"citation":{"abstract":"To report an experience with infliximab in severe corticosteroid-resistant Vogt-Koyanagi-Harada (VKH) disease.","abstract_source":"pubmed","altmetric_jid":"4f6fa5303cf058f6100042cb","authors":[" Mathieu Zmuda"],"doi":"10.3109\/09273948.2013.775312","first_seen_on":"2013-04-29T20:30:13+00:00","issns":[],"journal":"Ocular Immunology & Inflammation","last_mentioned_on":1367267279,"links":["http:\/\/informahealthcare.com\/doi\/abs\/10.3109\/09273948.2013.775312#.UX7XkqwTXQk.twitter","http:\/\/informahealthcare.com\/doi\/abs\/10.3109\/09273948.2013.775312","http:\/\/www.tandfonline.com\/doi\/abs\/10.3109\/09273948.2013.775312"],"pmid":"23617262","pubdate":"2013-04-27T00:00:00+00:00","publisher_subjects":[{"name":"Immunology","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["ophthalmology","allergyandimmunology"],"title":"Successful Use of Infliximab Therapy in Sight-threatening Corticosteroid-resistant Vogt-Koyanagi-Harada Disease","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/successful-infliximab-therapy-sightthreatening-corticosteroidresistant-vogtkoyanagiharada-disease"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":5041086,"mean":5.964734720803,"rank":2674779,"this_scored_higher_than_pct":33,"this_scored_higher_than":1692328,"rank_type":"exact","sample_size":5041086,"percentile":33},"similar_age_3m":{"total_number_of_other_articles":92768,"mean":7.2091323854388,"rank":46417,"this_scored_higher_than_pct":36,"this_scored_higher_than":34265,"rank_type":"exact","sample_size":92768,"percentile":36},"this_journal":{"total_number_of_other_articles":169,"mean":1.2948214285714,"rank":62,"this_scored_higher_than_pct":47,"this_scored_higher_than":80,"rank_type":"exact","sample_size":169,"percentile":47},"similar_age_this_journal_3m":{"total_number_of_other_articles":13,"mean":1.675,"rank":8,"this_scored_higher_than_pct":23,"this_scored_higher_than":3,"rank_type":"exact","sample_size":13,"percentile":23}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Librarian":1,"Researcher":4,"Student  > Ph. D. Student":1,"Student  > Master":1,"Student  > Bachelor":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":7,"Agricultural and Biological Sciences":1,"Biochemistry, Genetics and Molecular Biology":1}}},"geo":{"mendeley":{"DK":1,"PE":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/IHC_Ophth\/statuses\/328968929127047168","license":"public","citation_ids":[1420258],"posted_on":"2013-04-29T20:27:59+00:00","author":{"name":"T&F Ophthalmology","url":"http:\/\/www.tandfonline.com","image":"https:\/\/pbs.twimg.com\/profile_images\/668814009869582336\/aoRNCrx2_normal.png","description":"Keep up to date with all the latest news and content from the Taylor & Francis Ophthalmology portfolio.","id_on_source":"IHC_Ophth","tweeter_id":"389588993","geo":{"lt":null,"ln":null},"followers":1084},"tweet_id":"328968929127047168"}]}}